Adapting the Comprehensive Unit Safety Program (CUSP) implementation strategy to increase delivery of evidence-based cardiovascular risk factor care in community mental health organizations: protocol for a pilot study.

Cardiovascular Culture Integrated care Self-efficacy Serious mental illness

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
04 Mar 2021
Historique:
received: 08 02 2021
accepted: 15 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 6 3 2021
Statut: epublish

Résumé

People with serious mental illnesses (SMI) such as schizophrenia and bipolar disorder experience excess mortality driven in large part by high rates of poorly controlled and under-treated cardiovascular risk factors. In the USA, integrated "behavioral health home" models in which specialty mental health organizations coordinate and manage physical health care for people with SMI are designed to improve guideline-concordant cardiovascular care for this group. Such models have been shown to improve cardiovascular care for clients with SMI in randomized clinical trials, but real-world implementation has fallen short. Key implementation barriers include lack of alignment of specialty mental health program culture and physical health care coordination and management for clients with SMI and lack of structured protocols for conducting effective physical health care coordination and management in the specialty mental health program context. This protocol describes a pilot study of an implementation intervention designed to overcome these barriers. This pilot study uses a single-group, pre/post-study design to examine the effects of an adapted Comprehensive Unit Safety Program (CUSP) implementation strategy designed to support behavioral health home programs in conducting effective cardiovascular care coordination and management for clients with SMI. The CUSP strategy, which was originally designed to improve inpatient safety, includes provider training, expert facilitation, and implementation of a five-step quality improvement process. We will examine the acceptability, appropriateness, and feasibility of the implementation strategy and how this strategy influences mental health organization culture; specialty mental health providers' self-efficacy to conduct evidence-based cardiovascular care coordination and management; and receipt of guideline-concordant care for hypertension, dyslipidemia, and diabetes mellitus among people with SMI. While we apply CUSP to the implementation of evidence-based hypertension, dyslipidemia, and diabetes care, this implementation strategy could be used in the future to support the delivery of other types of evidence-based care, such as smoking cessation treatment, in behavioral health home programs. CUSP is designed to be fully integrated into organizations, sustained indefinitely, and used to continually improve evidence-based practice delivery. ClinicalTrials.gov, NCT04696653 . Registered on January 6, 2021.

Sections du résumé

BACKGROUND BACKGROUND
People with serious mental illnesses (SMI) such as schizophrenia and bipolar disorder experience excess mortality driven in large part by high rates of poorly controlled and under-treated cardiovascular risk factors. In the USA, integrated "behavioral health home" models in which specialty mental health organizations coordinate and manage physical health care for people with SMI are designed to improve guideline-concordant cardiovascular care for this group. Such models have been shown to improve cardiovascular care for clients with SMI in randomized clinical trials, but real-world implementation has fallen short. Key implementation barriers include lack of alignment of specialty mental health program culture and physical health care coordination and management for clients with SMI and lack of structured protocols for conducting effective physical health care coordination and management in the specialty mental health program context. This protocol describes a pilot study of an implementation intervention designed to overcome these barriers.
METHODS METHODS
This pilot study uses a single-group, pre/post-study design to examine the effects of an adapted Comprehensive Unit Safety Program (CUSP) implementation strategy designed to support behavioral health home programs in conducting effective cardiovascular care coordination and management for clients with SMI. The CUSP strategy, which was originally designed to improve inpatient safety, includes provider training, expert facilitation, and implementation of a five-step quality improvement process. We will examine the acceptability, appropriateness, and feasibility of the implementation strategy and how this strategy influences mental health organization culture; specialty mental health providers' self-efficacy to conduct evidence-based cardiovascular care coordination and management; and receipt of guideline-concordant care for hypertension, dyslipidemia, and diabetes mellitus among people with SMI.
DISCUSSION CONCLUSIONS
While we apply CUSP to the implementation of evidence-based hypertension, dyslipidemia, and diabetes care, this implementation strategy could be used in the future to support the delivery of other types of evidence-based care, such as smoking cessation treatment, in behavioral health home programs. CUSP is designed to be fully integrated into organizations, sustained indefinitely, and used to continually improve evidence-based practice delivery.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov, NCT04696653 . Registered on January 6, 2021.

Identifiants

pubmed: 33663620
doi: 10.1186/s43058-021-00129-6
pii: 10.1186/s43058-021-00129-6
pmc: PMC7931551
doi:

Banques de données

ClinicalTrials.gov
['NCT04696653']

Types de publication

Journal Article

Langues

eng

Pagination

26

Subventions

Organisme : NIMH NIH HHS
ID : P50 MH115842
Pays : United States
Organisme : NIMH NIH HHS
ID : P50MH115842-03
Pays : United States

Références

Gen Hosp Psychiatry. 2018 Mar - Apr;51:54-62
pubmed: 29316451
JAMA Psychiatry. 2015 Dec;72(12):1172-81
pubmed: 26509694
Adm Policy Ment Health. 2018 Mar;45(2):276-285
pubmed: 28884234
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
Health Serv Res. 2006 Aug;41(4 Pt 2):1599-617
pubmed: 16898981
Med Care. 2014 Mar;52 Suppl 3:S101-9
pubmed: 24561748
J Crit Care. 2008 Jun;23(2):207-21
pubmed: 18538214
Psychiatr Serv. 1998 Dec;49(12):1568-72
pubmed: 9856618
Soc Psychiatry Psychiatr Epidemiol. 2012 Aug;47(8):1291-9
pubmed: 21984654
Schizophr Res. 2015 Jul;165(2-3):227-35
pubmed: 25936686
Psychiatr Serv. 2020 Nov 1;71(11):1163-1169
pubmed: 32487007
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
J Gen Intern Med. 2020 Dec;35(12):3745-3746
pubmed: 31845107
Psychiatr Serv. 2013 Jul 1;64(7):660-5
pubmed: 23584674
Implement Sci. 2014 Apr 05;9(1):43
pubmed: 24708893
Med Care. 2019 Jan;57(1):79-84
pubmed: 30439791
Lancet. 2004 Jun 19;363(9426):2063-72
pubmed: 15207959
N Engl J Med. 2017 Feb 2;376(5):405-407
pubmed: 27973984
Am J Psychiatry. 2017 Mar 1;174(3):246-255
pubmed: 27631964
JAMA. 2007 Oct 17;298(15):1794-6
pubmed: 17940236
Gen Hosp Psychiatry. 2002 Jul-Aug;24(4):197-202
pubmed: 12100830
BMJ. 2008 Oct 06;337:a1714
pubmed: 18838424
Gen Hosp Psychiatry. 2015 May-Jun;37(3):199-222
pubmed: 25881768
Jt Comm J Qual Patient Saf. 2010 Jun;36(6):252-60
pubmed: 20564886
Br J Psychiatry. 1997 Dec;171:502-8
pubmed: 9519087
Health Aff (Millwood). 2011 Apr;30(4):628-34
pubmed: 21471482
JAMA Netw Open. 2020 Jun 1;3(6):e207247
pubmed: 32530472
Am J Med. 2005 Apr;118 Suppl 2:15S-22S
pubmed: 15903291
Rand Health Q. 2014 Dec 30;4(3):13
pubmed: 28560082
J Am Board Fam Med. 2015 Sep-Oct;28 Suppl 1:S41-51
pubmed: 26359471
Psychiatr Serv. 2009 Jun;60(6):761-5
pubmed: 19487344
Curr Treat Options Psychiatry. 2018 Sep;5(3):334-344
pubmed: 30083495
Psychiatr Serv. 2002 May;53(5):565-73
pubmed: 11986504
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
J Gen Intern Med. 2020 Nov;35(11):3148-3158
pubmed: 32128686
Schizophr Res. 2013 Oct;150(1):42-50
pubmed: 23911259
Br J Psychiatry. 2019 Apr 26;:1-4
pubmed: 31025616
Arch Gen Psychiatry. 2001 Sep;58(9):861-8
pubmed: 11545670
Compr Psychiatry. 2016 Nov;71:106-120
pubmed: 27653782
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783
JAMA. 2010 May 19;303(19):1972-3
pubmed: 20483975
Int Rev Psychiatry. 2018 Dec;30(6):224-241
pubmed: 30822169
J Am Coll Surg. 2015 Sep;221(3):669-77; quiz 785-6
pubmed: 26228010

Auteurs

Emma Elizabeth McGinty (EE)

Johns Hopkins University Bloomberg School of Public Health, 624 N. Broadway, Room 359, Baltimore, MD, 21205, USA. bmcginty@jhu.edu.

David Thompson (D)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Karly A Murphy (KA)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Elizabeth A Stuart (EA)

Johns Hopkins University Bloomberg School of Public Health, 624 N. Broadway, Room 359, Baltimore, MD, 21205, USA.

Nae-Yuh Wang (NY)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Arlene Dalcin (A)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Elizabeth Mace (E)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Joseph V Gennusa (JV)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Gail L Daumit (GL)

Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21202, USA.

Classifications MeSH